About this item:

480 Views | 508 Downloads

Author Notes:

Correspondence: J.Brooke@umcutrecht.nl

RB performed the literature review, data gathering, statistical analysis and the writing of the manuscript.

MK performed the literature, statistical analysis and the drafting of the manuscript.

NM performed the data gathering, clinical and research analysis and drafting of the manuscript. .

PT performed the literature review, statistical analysis, and drafting of the manuscript.

All authors read and approved the final manuscript.

The authors declare that they have no competing interests.

Subjects:

Keywords:

  • Q fever
  • Dose response
  • Challenge study
  • Risk analysis
  • Beta-poisson

Journal Title:

BMC Infectious Diseases

Volume:

Volume 13

Publisher:

, Pages 488-488

Type of Work:

Article | Final Publisher PDF

Abstract:

Background: The recent outbreak of Q fever in the Netherlands between 2007 and 2009 is the largest recorded Q fever outbreak. Exposure to Coxiella burnetii may cause Q fever but the size of the population exposed during the outbreak remained uncertain as little is known of the infectivity of this pathogen. The quantification of the infectiousness and the corresponding response is necessary for assessing the risk to the population. Methods: A human challenge study was published in the 1950s but this study quantified the dose of C. burnetii in relative units. Data from a concurrent guinea pig challenge study were combined with a recent study in which guinea pigs were challenged with a similar aerosol route to quantify human exposure. Concentration estimates for C. burnetii are made jointly with estimates of the dose response parameters in a hierarchical Bayesian framework. Results: The dose for 50% infection (InfD50%) in human subjects is 1.18 bacteria (95% credible interval (CI) 0.76-40.2). The dose for 50% illness (IllD50) in challenged humans is 5.58 (95%CI 0.89-89.0) bacteria. The probability of a single viable C. burnetii causing infection in humans is 0.44 (95%CI 0.044-0.59) and for illness 0.12 (95%CI 0.0006-0.55). Conclusions: To our knowledge this is the first human dose–response model for C. burnetii. The estimated dose response relation demonstrates high infectivity in humans. In many published papers the proportion of infected individuals developing illness is reported to be 40%. Our model shows that the proportion of symptomatic infections may vary with the exposure dose. This implies that presence of these bacteria in the environment, even in small numbers, poses a serious health risk to the population.

Copyright information:

© 2013 Brooke et al.; licensee BioMed Central Ltd.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 2.0 Generic License (http://creativecommons.org/licenses/by/2.0/).

Creative Commons License

Export to EndNote